Advanced Filters
noise

Celiac Disease Clinical Trials

A listing of Celiac Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,204 clinical trials

Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus

It is a multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of HDM1005 injection in nondiabetic obese adults.

18 - 65 years of age All Phase 2
C Christopher T Minson, PhD

Repeated Far Infrared Sauna Bathing in Adults With Obesity

This is a clinical trial to determine if 30 sessions of far infrared sauna bathing can improve cardiovascular and metabolic function in adults with obesity.

18 - 59 years of age All Phase N/A

Individualization of Dosage Regimens in Obese Patients: Application to Acyclovir

The number of obese people will reach 50% of the world population by 2035. Obesity is a chronic disease. For obese patients, dosage regimens have been determined for patients with a "normal" BMI between 20-30 kg/m2. Based on plasma and urine concentrations, a pharmacokinetic model will be performed to study …

18 - 50 years of age All Phase 1
S Sylvie Kropáčová

Non-invasive Brain Stimulation to Prepare the Patient for Bariatric Surgery (REBAS)

Obesity is a chronic metabolic condition characterized by excessive accumulation of body fat, which triggers physiological mechanisms that increase the risk of a wide range of health problems. The most effective treatment for severe obesity is metabolic-bariatric surgery, which can lead to a 15-20% weight reduction, significantly lowering the risks …

18 - 65 years of age All Phase N/A
C Camila Pereira-Eshraghi, MD. MS.

Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

The prevalence of childhood obesity in the United States has more than tripled in the past four decades affecting one in every five adolescent girls and is disproportionally higher among racial and/or ethnic minorities. Normal puberty onset and progression is dependent on normal hypothalamic-pituitary-gonadal (HPG) axis which is affected by …

12 - 18 years of age Female Phase N/A

The Role of the Amylin Analogue Cagrilintide in Bone Metabolism

In this study we will investigate how the medicine cagrilintide affects bone health in women after menopause with obesity during weight loss, compared to treatment with placebo (the dummy medicine with no active substances) and semaglutide. The purpose is to examine whether cagrilintide can reduce the decline in bone mass …

50 - 70 years of age Female Phase 1
J Jozef Ukropec, PhD, DSc

DIGITALIZATION OF PERSONALISED HEALTH RISK MANAGEMENT

The principal objective of the project is: to bring together academic and business research organisations in a joint partnership integrating technological and social innovation, in order to develop proof-of-concept of a scalable and cost effective personalised digital health program for (pre)obesity patients, by integrating, in an ethical manner, adaptive AI …

25 - 65 years of age All Phase N/A

A Study of BGM0504 in Participants With Obesity

To evaluate the efficacy and safety of BGM0504 compared with Tirzepatide in adult participants who have obesity without diabetes after 26 weeks of treatment.

18 - 65 years of age All Phase 2
J Juan Jose Vendrell Ortega, PhD, MD, Professor

Circulating Microvesicles Regulating Metabolic Homeostasis in Obesity After Caloric Restriction Programs

The main aim of the present study is to evaluate the effectiveness of two dietary protocols: Daily Caloric Restriction (DCR) and Early Time-Restricted Feeding + DCR (eTRE) on metabolic homeostasis and the influence of circulating extracellular vesicles (EVs) as inter-organ communication elements in obese patients.

18 - 70 years of age All Phase N/A

Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108

The study looks at the safety and blood levels of the study drug INV-347 in participants who were previously dosed with INV-347 in study INV-CL-108. Participants will not get any study drug in this study as it looks into the safety of a drug previously dosed. The study will last …

18 years of age All Phase 1

Simplify language using AI